xanthenes has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, Y; Kariya, T; Maruyama, S; Matsukawa, Y; Mizuno, M; Nishimura, H; Sakata, F; Suzuki, Y; Takei, Y | 1 |
1 other study(ies) available for xanthenes and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Topics: Aged; Aged, 80 and over; Amino Acids; Angiogenesis Inhibitors; Animals; Cell Line; Disease Models, Animal; Female; Fibroblasts; Humans; Male; Middle Aged; Neovascularization, Pathologic; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Signal Transduction; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Xanthenes | 2018 |